 |
Business partners: |
|
| |
Accelrys, Inc./SciTegic
Molecular Networks partners SciTegic's Independent Software Vendor (ISV) Program
and is developing and distributing components that integrate its software technology
into Pipeline Pilot.
For more information about the integration of CORINA, ADRIANA.Code, SYLVIA,
isoCYP and MN.Tools into Pipeline Pilot see the
or the page. |
| |
Biomax Informatics AG
Biomax Informatics and Molecular Networks entered into a strategic partnership in
order to effectively join bioinformatics and chemoinformatics into one stream of
research.
For more information about the alliance with Biomax Informatics
AG see the . |
| |
BioSolveIT GmbH
BioSolveIT and Molecular Networks collaborate for joint marketing on the North
American market, for a seamless interface beetween BioSolveIT's premium docking
program FlexX and CORINA and in the BMBF funded project NovoBench (see below).
For more information about the joint marketing with BioSolveIT see the
. |
| |
Chemical Computing Group, Inc.
Since version 2007.09, Chemical Computing Group's (CCG) comprehensive and powerful
life science modeling suite Molecular Operating Environment - MOE - provides an
interface to seamlessly integrate CORINA.
For more information about the integration of CORINA into the MOE see the
. |
| |
Inte:Ligand GmbH
Inte:Ligand's high quality and flexible virtual compound library generation platform
ilib diverse has an integrated module of CORINA. Furthermore, Inte:Ligand and Molecular
Networks share complementary technology for mutual benefit.
More information is available in the
. |
| |
MDL
Information Systems, Inc.
MDL Information Systems, now with Symyx Technologies, Inc. and the recognized leader in discovery
informatics for the life sciences and chemistry in industry
and academia, uses CORINA-generated 3D molecular models in its molecule databases.
For more information about the collaboration with MDL see the
|
| |
|
Publicly funded projects: |
|
| |
BFAM project
Bioinformatics for the Functional Analysis of Mammalian Genomes
supported by the |
| |
NovoBench project
De novo Design of Lead compounds with high Propensity of Being Biologically
Active and Synthetically Feasible
supported by the |
| |
HepatoSys project
Modeling and Simulation of the Metabolism of Drugs
supported by the |
| |
